Heart News and Research

RSS

Essilor introduces first high performance anti-fogging lenses

Essilor today announced the launch of Optifog, the first high-performance anti-fogging lenses, in response to high consumer demand. This new category of lenses represents a major technological breakthrough in keeping with the long tradition of innovation at Essilor.

26 Aug 2011

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets for the treatment of adults with type 2 diabetes.

26 Aug 2011

Antidepressant alert – Citalopram associated to heart rhythm disturbances

Antidepressant citalopram (Celexa, Forest Laboratories) should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration (FDA) warns.

25 Aug 2011

New guidance for blood pressure monitoring

Blood pressure has been measured and recorded in the same way for nearly a century. This is set to change. Researchers believe that the earlier way has led to the misdiagnosis of many. This could be due to a phenomenon called “white coat hypertension” or rise in the blood pressure due to nervousness on meeting the medical staff. It is seen that at least 25% of the population suffers from white coat hypertension.

25 Aug 2011

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.

25 Aug 2011

Insight into how bacterial toxins cause human diseases may help improve treatment

A better understanding of how bacterial toxins cause common human diseases may lead to their improved treatment and prevention according to a paper just published by Irish and US scientists in Nature Reviews Microbiology.

25 Aug 2011

Tropical plants may contain basis of new and effective treatments for ovarian cancer

Tropical plants may contain the basis of new and effective treatments for ovarian cancer, according to researchers at the Universities of Strathclyde and Portsmouth.

25 Aug 2011

ICU patients less likely to renew prescriptions for chronic diseases after discharge

Patients often do not renew prescriptions for their chronic diseases after they are released from hospital.

25 Aug 2011

Scientists discover mutant hypertension gene in chickens similar to that of humans

Scientists from the University of Abertay Dundee have discovered that a gene which, when severely mutated, causes blindness and kidney abnormalities in chickens, is the same as one that predisposes humans to hypertension.

25 Aug 2011

Transradial cardiac catheterizations reduce complications, increase patient comfort

Each year, more than one million cardiac catheterizations are performed in the United States, and most of these procedures are performed through the groin to access the arteries that provide blood supply to the heart.

25 Aug 2011

Study finds biological indicators that help explain why obese people develop chronic diseases

UC Davis Health System researchers have discovered biological indicators that help explain why some obese people develop chronic diseases such as diabetes and heart disease, and others do not.

25 Aug 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2011.

25 Aug 2011

More than eight out of 10 homeless people have at least one chronic health condition

More than eight out of 10 homeless people surveyed by researchers at St. Michael's Hospital and elsewhere have at least one chronic health condition and more than half have a mental health problem.

25 Aug 2011

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Cortex Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent that protects the use of AMPAKINE molecules for the treatment or prevention of respiratory depression.

25 Aug 2011

Married couples survive heart bypass surgery longer: Study

Research suggests that a happy marriage lengthens the lives of cardiac bypass patients. The researchers say that supportive spouses can provide encouragement to make it through tough lifestyle changes.

24 Aug 2011

Heart failure risk rises in people with diastolic dysfunction: Study

New research suggests that a common form of heart trouble called diastolic dysfunction appears to worsen over time and may lead to an increased risk of heart failure. In people with diastolic dysfunction, which often comes with advancing age, the heart's left ventricle fills with blood in an abnormal way and is accompanied by elevated filling pressures.

24 Aug 2011

Psoriasis drug and heart attack risk association unclear: Study

According to American researchers, although a review of published studies reveals that a new and highly effective class of psoriasis drugs does not appear to raise the risk of heart problems, the studies may not have been big enough to detect rare cases.

24 Aug 2011

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Physio-Control, Inc., a global leader in emergency medical solutions and wholly‐owned subsidiary of Medtronic, Inc.,, today announced commercial availability of the ReadyLink™ 12-Lead ECG device, a new, U.S. Food and Drug Administration (FDA) 510(k)-cleared solution designed to improve care for heart attack patients and expand regional STEMI systems.

From Medtronic 24 Aug 2011

Major new guideline on treatment of high blood pressure

The way blood pressure is diagnosed and treated is set to be revolutionised following new guidelines for the medical profession issued by NICE and developed in conjunction with the British Hypertension Society (BHS).

24 Aug 2011

Neovasc second quarter revenues decrease 8% to $879,405

Neovasc Inc., today announced financial results for the three and six months ended June 30, 2011.

24 Aug 2011

Heart News and Research

Essilor introduces first high performance anti-fogging lenses

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Antidepressant alert – Citalopram associated to heart rhythm disturbances

New guidance for blood pressure monitoring

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

Insight into how bacterial toxins cause human diseases may help improve treatment

Tropical plants may contain basis of new and effective treatments for ovarian cancer

ICU patients less likely to renew prescriptions for chronic diseases after discharge

Scientists discover mutant hypertension gene in chickens similar to that of humans

Transradial cardiac catheterizations reduce complications, increase patient comfort

Study finds biological indicators that help explain why obese people develop chronic diseases

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

More than eight out of 10 homeless people have at least one chronic health condition

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Married couples survive heart bypass surgery longer: Study

Heart failure risk rises in people with diastolic dysfunction: Study

Psoriasis drug and heart attack risk association unclear: Study

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Major new guideline on treatment of high blood pressure

Neovasc second quarter revenues decrease 8% to $879,405

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News